Metformin treats polycystic ovarian syndrome by improving insulin sensitivity
Metformin is widely recognized as a standard treatment for polycystic ovary syndrome (PCOS) because it targets and improves underlying insulin resistance and metabolic dysfunction.
Multiple papers consistently state that metformin functions as an insulin sensitizer to treat the metabolic dysfunction and insulin resistance characteristic of polycystic ovary syndrome. No papers contradict this mechanism.
Liu S, Wang R, Yu W, Shi C, Wang X, Liu A, Zhang L. Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives.. 2026. https://doi.org/10.3390/nu18060964
Paper 0 highlights that insulin sensitizers like metformin are standard pharmacological treatments used to address underlying insulin resistance in polycystic ovary syndrome.
See more details
Sun C, Han Y, Pan Z, Li J, Cheng X, Sun M, Wang Y, Kuang H. Hypothalamic Inflammation as a Critical Link Between Metabolic Dysfunction and Impaired Endometrial Receptivity in Obese Polycystic Ovary Syndrome.. 2026. https://europepmc.org/article/MED/42466701
Paper 2 demonstrates that metformin improves insulin resistance and metabolic parameters in animal models of polycystic ovary syndrome.
Olewi NZ, Hassan AF. Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin.. 2026. https://doi.org/10.1007/s00210-026-05346-1
Paper 4 notes that traditional metformin therapy improves insulin sensitivity in polycystic ovary syndrome.
Singla J, Yadav S, Gayen JR. Polycystic ovary syndrome and insulin resistance: A focus on pathogenesis, risk factors, and therapeutic strategies.. 2026. https://doi.org/10.1016/j.jri.2026.104943
Paper 5 confirms that conventional therapeutic approaches for polycystic ovary syndrome focus on improving insulin sensitivity using agents such as metformin.
Trzcinski M, Chudzicka-Strugala I, Kim K, Piekarski P, Spaczynski R, Zwoździak B, Banaszewska B, Pawelczyk L, Chang RJ, Duleba AJ. Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome.. 2026. https://doi.org/10.1530/ec-26-0120
Paper 7 notes that metformin is frequently used in polycystic ovary syndrome treatment specifically to improve glucose metabolism and insulin levels.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt